Regorafenib: A Review in Hepatocellular Carcinoma

In conclusion, current evidence suggests that regorafenib is an important new targeted therapy option for the treatment of HCC patients who have progressed on sorafenib therapy.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research